Jupiter Asset Management Ltd. Makes New Investment in Cigna Group $CI

Jupiter Asset Management Ltd. purchased a new position in Cigna Group (NYSE:CI) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 33,952 shares of the health services provider’s stock, valued at approximately $9,345,000.

Several other large investors also recently made changes to their positions in the stock. Beacon Financial Strategies CORP bought a new position in shares of Cigna Group in the 4th quarter valued at approximately $28,000. Collier Financial acquired a new position in Cigna Group during the third quarter valued at approximately $34,000. Lodestone Wealth Management LLC acquired a new position in Cigna Group during the fourth quarter valued at approximately $32,000. Creative Financial Designs Inc. ADV raised its position in shares of Cigna Group by 147.3% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after purchasing an additional 81 shares during the period. Finally, Activest Wealth Management lifted its stake in shares of Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock worth $38,000 after buying an additional 126 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $277.08 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $73.30 billion, a PE ratio of 11.75, a price-to-earnings-growth ratio of 1.02 and a beta of 0.30. The firm has a fifty day moving average price of $278.32 and a two-hundred day moving average price of $276.88. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts expect that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio is 26.45%.

Insiders Place Their Bets

In related news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 205,904 shares of company stock worth $60,277,068. 0.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CI. Leerink Partners upped their price objective on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a report on Friday, February 6th. TD Cowen boosted their target price on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Morgan Stanley upped their price target on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Raymond James Financial set a $340.00 price target on Cigna Group in a research report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft cut Cigna Group from a “buy” rating to a “hold” rating and cut their price objective for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $339.50.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.